Norges Bank
IRWD icon

Norges Bank’s Ironwood Pharmaceuticals IRWD Stock Holding History

Norges Bank’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-252,291
Closed -$1.12M – 1795
2024
Q4 		$1.12M Sell
252,291
-141,975
-36% -$576K ﹤0.01% 1750
2024
Q3 		$1.62M Sell
394,266
-998,811
-72% -$5.37M ﹤0.01% 1682
2024
Q2 		$9.08M Buy
1,393,077
+743,898
+115% +$5.26M ﹤0.01% 1416
2024
Q1 		$5.65M Sell
649,179
-165,595
-20% -$2.01M ﹤0.01% 1593
2023
Q4 		$9.32M Sell
814,774
-104,275
-11% -$1.03M ﹤0.01% 1509
2023
Q3 		$8.85M Sell
919,049
-204,772
-18% -$2.01M ﹤0.01% 1521
2023
Q2 		$12M Sell
1,123,821
-412,953
-27% -$4.44M ﹤0.01% 1462
2023
Q1 		$16.2M Buy
1,536,774
+15,146
+1% +$170K ﹤0.01% 1372
2022
Q4 		$18.9M Buy
1,521,628
+37,854
+3% +$429K ﹤0.01% 1300
2022
Q3 		$15.4M Buy
1,483,774
+46,040
+3% +$522K ﹤0.01% 1341
2022
Q2 		$16.6M Sell
1,437,734
-1,613,987
-53% -$19M ﹤0.01% 1327
2022
Q1 		$38.4M Buy
3,051,721
+35,393
+1% +$406K 0.01% 1026
2021
Q4 		$35.2M Buy
3,016,328
+1,240,900
+70% +$15.2M 0.01% 1133
2021
Q3 		$23.2M Sell
1,775,428
-6,525
-0.4% -$84.3K 0.01% 1395
2021
Q2 		$22.9M Sell
1,781,953
-25,616
-1% -$293K 0.01% 1455
2021
Q1 		$20.2M Sell
1,807,569
-244,821
-12% -$2.59M ﹤0.01% 1539
2020
Q4 		$23.4M Hold
2,052,390
– – 0.01% 1475
2020
Q3 		$18.5M Sell
2,052,390
-419,589
-17% -$4.17M ﹤0.01% 1474
2020
Q2 		$25.5M Sell
2,471,979
-43,869
-2% -$449K 0.01% 1280
2020
Q1 		$25.4M Sell
2,515,848
-61,274
-2% -$720K 0.01% 1089
2019
Q4 		$34.3M Hold
2,577,122
– – 0.01% 1155
2019
Q3 		$22.1M Buy
2,577,122
+145,882
+6% +$1.42M 0.01% 1421
2019
Q2 		$26.6M Sell
2,431,240
-47,794
-2% -$535K 0.01% 1311
2019
Q1 		$28.1M Buy
2,479,034
+223,796
+10% +$2.5M 0.01% 1264
2018
Q4 		$19.6M Buy
2,255,238
+533,497
+31% +$6.12M 0.01% 1415
2018
Q3 		$26.6M Buy
1,721,741
+387,048
+29% +$6.12M 0.01% 1345
2018
Q2 		$21.4M Buy
1,334,693
+137,044
+11% +$2.03M 0.01% 1473
2018
Q1 		$15.5M Sell
1,197,649
-1,608,725
-57% -$20M 0.01% 1575
2017
Q4 		$35.2M Buy
2,806,374
+402,386
+17% +$5.26M 0.01% 1051
2017
Q3 		$31.8M Sell
2,403,988
-213,065
-8% -$2.93M 0.01% 1113
2017
Q2 		$41.4M Buy
2,617,053
+701,514
+37% +$10.2M 0.02% 873
2017
Q1 		$27.4M Buy
1,915,539
+487,663
+34% +$6.67M 0.01% 1166
2016
Q4 		$18.3M Buy
1,427,876
+161,589
+13% +$2.04M 0.01% 1379
2016
Q3 		$16.1M Buy
1,266,287
+362,747
+40% +$4.24M 0.01% 1374
2016
Q2 		$9.89M Buy
903,540
+16,238
+2% +$159K ﹤0.01% 1619
2016
Q1 		$8.13M Sell
887,302
-170,269
-16% -$1.4M ﹤0.01% 1663
2015
Q4 		$10.3M Buy
1,057,571
+133,011
+14% +$1.29M 0.01% 1575
2015
Q3 		$8.07M Sell
924,560
-303,684
-25% -$2.83M ﹤0.01% 1684
2015
Q2 		$12.4M Hold
1,228,244
– – 0.01% 1493
2015
Q1 		$16.5M Buy
1,228,244
+1,128,545
+1,132% +$14.8M 0.01% 1324
2014
Q4 		$1.28M Buy
+99,699
New +$1.14M ﹤0.01% 2159
2014
Q2 		– Sell
-684,566
Closed -$7.06M – 2250
2014
Q1 		$7.06M Sell
684,566
-342,885
-33% -$3.86M ﹤0.01% 1755
2013
Q4 		$9.99M Hold
1,027,451
– – 0.01% 1574
2013
Q3 		$10.2M Buy
+1,027,451
New +$10.1M 0.01% 1551

Other funds holding IRWD

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Norges Bank's IRWD Position: Q1 2025 in Review

Norges Bank sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 252,291 shares — an estimated $1.12M sold.

Norges Bank first reported a position in IRWD in Q3 2013 and held it in 44 quarters. The position peaked at $41.4M in Q2 2017. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

  • Norges Bank reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Norges Bank sold 252,291 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $1.12M.
  • Norges Bank first reported a position in Ironwood Pharmaceuticals in Q3 2013 and held it in 44 quarters.
  • Norges Bank's Ironwood Pharmaceuticals position peaked at $41.4M in Q2 2017.
  • 200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on Norges Bank's 13F filing for Q1 2025, filed 13 May 2025.